Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years

Stefania La Grutta, Franco Frati, Stefania La Grutta, Laura Sensi, Giovanbattista Pajno, Cristoforo Incorvaia, Francesco Marcucci, Alessandro Fiocchi, Francesco Pezzuto

    Risultato della ricerca: Article

    105 Citazioni (Scopus)

    Abstract

    The minimum age to start specific immunotherapy with inhalant allergens in children has not been clearly established, and position papers discourage its use in children younger than 5 years.
    Lingua originaleEnglish
    pagine (da-a)254-258
    Numero di pagine5
    RivistaANNALS OF ALLERGY ASTHMA & IMMUNOLOGY
    Volume95
    Stato di pubblicazionePublished - 2005

    All Science Journal Classification (ASJC) codes

    • Immunology and Allergy
    • Immunology
    • Pulmonary and Respiratory Medicine

    Fingerprint Entra nei temi di ricerca di 'Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years'. Insieme formano una fingerprint unica.

  • Cita questo

    La Grutta, S., Frati, F., La Grutta, S., Sensi, L., Pajno, G., Incorvaia, C., Marcucci, F., Fiocchi, A., & Pezzuto, F. (2005). Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 95, 254-258.